NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cristal Therapeutics

Cristal Therapeutics

Private
MaastrichtHealthcare & Life Scienceshttps://cristaltherapeutics.com

Last Round

Grant

Jul 2, 2020

Total Funding Raised

$24.08M

Company Overview

Cristal Therapeutics is a biotechnology company that develops nanomedicines and bioconjugation technologies designed to improve targeted therapy for cancer and other diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

nanomedicinenanoparticle drug deliverydrug delivery technologytargeted drug deliverypolymeric nanoparticlesoncology drug deliveryclinical stage pharmapharma licensingbioconjugation platformclick chemistrysolid tumor therapyantibody-drug conjugatesADCvaccine delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cristal Therapeutics Comparables

Compare Cristal Therapeutics with similar companies based on industry and business-model similarity.

Cristal Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NaDeNo Nanoscience
83%
Centrose
77%
Sapu Nano
77%

Cristal Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 2, 2020
GrantNov 28, 2017
Series BJan 19, 2017
Series ADec 15, 2014
SeedJul 1, 2013

Key People

Founding team and executive leadership

Werner Cautreels

Chief Executive Officer

Executive Team

Cristal Therapeutics Investors

Notable investors and investment history

Cristal Therapeutics investors
InvestorRounds
Brabantse Ontwikkelings MaatschappijSeries B
European Commission (Horizon Europe)Grant
European CommissionGrant
Thuja CapitalSeries A, Seed
Brightlands Venture PartnersSeries B, Series A
LIOFSeries B, Seed
BioGeneration VenturesSeries B, Series A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 26, 2025

    Partnered with Curapath to expand CliCr(R) platform.

Cristal Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cristal Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cristal Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMaastricht
Employee Range4
Year Founded2011
Last FundingJul 2, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.